Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Demant

213.40 DKK

+0.85 %

Less than 1K followers

DEMANT

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Demant

2019202020212022202320242025
Revenue14,946.014,469.018,388.019,705.022,443.022,419.022,971.0
growth-%-3.2 %27.1 %7.2 %13.9 %-0.1 %2.5 %
EBITDA3,075.02,541.04,479.04,383.05,482.05,761.05,351.0
EBIT2,151.01,530.03,445.03,207.04,148.04,528.03,832.0
Profit before taxes1,911.01,336.03,243.02,927.03,394.03,716.03,101.0
Net income1,467.01,134.02,528.02,084.01,798.02,388.01,544.0
EPS5.984.5910.289.218.0410.997.31
Dividend0.000.000.000.000.000.000.00
Dividend ratio0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%20.6 %17.6 %24.4 %22.2 %24.4 %25.7 %23.3 %
EBIT-%14.4 %10.6 %18.7 %16.3 %18.5 %20.2 %16.7 %
ROE19.2 %13.7 %31.7 %24.3 %19.3 %24.8 %15.6 %
ROI6.7 %5.2 %10.2 %7.0 %5.9 %7.4 %4.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.